<DOC>
	<DOC>NCT00495196</DOC>
	<brief_summary>The purpose of the trial is to investigate the cardiovascular response to peripheral chemoreceptor stimulation in Congestive Heart Failure with Cheyne- Stokes Respiration</brief_summary>
	<brief_title>Cardiovascular Responses in Congestive Heart Failure With Cheyne- Stokes Respiration</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Cheyne-Stokes Respiration</mesh_term>
	<criteria>Moderate to severe heart failure (NYHA Class II or above) on optimal medical therapy LVEF less than or equal to 45% Stable condition as defined as no hospital admission or changes to medical therapy within two weeks prior to enrolment Patients taking known respiratory stimulants or depressants Clinically significant asthma requiring therapy Significant parenchymal lung disease Primary pulmonary hypertension Myocardial infarction within three months prior to enrolment Patients with cardiac resynchronisation devices and permanent pacemakers Anaemic (haemoglobin &lt; 12g/dL)</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2010</verification_date>
</DOC>